U.S. Consumer Finance Stock News

Huntington Ingalls Industries recently secured ratification of new collective bargaining agreements at its Ingalls Shipbuilding division, granting union-represented workers an immediate 18% or higher base wage increase and extending contracts through March 8, 2031. This historic wage deal, coupled with HII’s broader workforce development push, signals a long-term commitment to labor stability, skills growth, and production throughput across its shipyards. We’ll now examine how this long-term...

Western Midstream Partners overview Western Midstream Partners (WES) has drawn investor attention after recent trading left the units at a last close of US$41.66, prompting a closer look at its returns and current valuation metrics. See our latest analysis for Western Midstream Partners. The recent 0.8% 1-day share price return to US$41.66 sits on top of a 5.6% 90-day share price return, while the 5-year total shareholder return of about 2.4x highlights how longer-term investors have been...

In Q4 2025, Rithm Capital reported non-GAAP earnings available for distribution of US$0.74 per share, beating consensus by 29%, with revenue up 18.4% year over year and total investable assets surpassing US$100.00 billion after acquiring Crestline Management and Paramount Group's office portfolio. The company also highlighted its evolution into an alternative asset manager, with US$38.00 billion of assets under management via Sculptor Capital and an intention to convert to a C-Corp so it can...

Wondering whether Pfizer at a last close of US$26.97 is genuinely offering value or just looks cheap on the surface? This article breaks down what the current price might be telling you. The stock's returns of 1.4% over 7 days, 1.2% over 30 days, 7.1% year to date and 10.7% over 1 year sit alongside longer term 3 year and 5 year returns of 19.6% and 5.5% declines, which can signal changing views on both its potential and its risks. Recent news around Pfizer has centered on the evolution of...

Tripadvisor (TRIP) has drawn fresh attention after entering a cooperation agreement with activist investor Starboard Value, adding two Starboard backed directors to its board and expanding the director slate ahead of the 2026 annual meeting. See our latest analysis for Tripadvisor. The cooperation agreement with Starboard comes after a period of weaker momentum, with a 30 day share price return of 13.51% decline and a year to date share price return of 36.13% decline. The 1 year total...

Earlier this month, Stifel Financial Corp. added Ajay Pathak and Bill Reisner as Managing Directors to co-lead a differentiated healthcare-focused public finance practice in St. Louis, aiming to deepen capital markets and advisory services for hospitals and health systems. This move builds on a recent milestone year in which Stifel exceeded US$5.00 billion in net revenue, raised its dividend for the ninth consecutive year, and announced a 3-for-2 stock split, underlining its push to...

Satellogic (SATL) is back in focus after unveiling Merlin, a planned constellation designed to remap the planet daily at one meter resolution and aiming to support defense, intelligence, and commercial monitoring use cases. See our latest analysis for Satellogic. Merlin and the recent earnings update arrive after a sharp swing in sentiment. A 77.72% 90 day share price return and an 83.16% year to date share price return contrast with a 1 year total shareholder return decline of 11.14%, which...

Corcept Therapeutics (CORT) has drawn attention after recent trading moves, with the stock last closing at US$34.64. Investors are weighing its recent share performance in relation to the company’s current earnings profile and valuation signals. See our latest analysis for Corcept Therapeutics. The recent 1 day share price return of 1.64% and 7 day share price return of 7.64% come after a much weaker 90 day share price return of 57.75% and a 1 year total shareholder return of 41.75%. As a...

Why Tango Therapeutics Is On Investors’ Radar Tango Therapeutics (TNGX) has drawn attention after a very large 1 year total return of 10.16%, alongside sizeable moves over the past month and past 3 months. For a precision oncology company still reporting a net loss of US$101.594 million on revenue of US$62.384 million, that kind of share price performance naturally raises questions about how investors are weighing its current fundamentals. See our latest analysis for Tango Therapeutics. The...

Context for Ashland after recent share price moves Ashland (ASH) has come back into focus for investors after a period of weaker share performance, with the stock showing declines over the past month, past 3 months, year to date, and over the past year. See our latest analysis for Ashland. At a share price of $48.81, Ashland’s recent 1 month share price return of 24.68% and 3 year total shareholder return of 47.02% point to pressure on sentiment rather than building momentum. If Ashland’s...

Adobe agreed to acquire Semrush for about $1.9b, aiming to add AI powered performance marketing and search capabilities to its product stack. The company is rolling out autonomous AI agents internally to support operations, with reported efficiency gains across key workflows. These moves come alongside an active CEO transition process that could reshape leadership priorities at Adobe. Adobe, NasdaqGS:ADBE, is making these moves while its share price stands at $248.15, with a value score of...

Earlier in March 2026, Diamondback Energy completed a follow-on equity offering of 11,000,000 common shares at US$173 each, raising about US$1.90 billion at a per-share discount of US$2.81. This sizable capital raise, which increases the company’s share count, could influence how investors assess its future capital allocation and production plans. Next, we’ll examine how this sizeable equity raise may reshape Diamondback Energy’s investment narrative centered on consolidation, efficiency and...

StepStone Group (STEP) has put two clear signals in front of investors: a new share repurchase program of up to US$100 million and a broad round of senior promotions across its global platform. See our latest analysis for StepStone Group. Those moves come as the share price sits at US$46.73, with a 7 day share price return of 4.1% but a 90 day share price return decline of 29.7%, alongside a 3 year total shareholder return of about 2.1x and a 1 year total shareholder return decline of 15.1%,...

Hilton Grand Vacations (HGV) recently opened Tradimo Kyoto Gojo in Japan, adding 63 one bedroom suites and expanding its resort footprint in Kyoto, while emphasizing sustainable tourism and local community partnerships. See our latest analysis for Hilton Grand Vacations. Despite the Kyoto opening and recent board changes, HGV’s share price has faced a 17.1% decline over the past 30 days and an 11.54% year to date share price return, while the 1 year total shareholder return is 2.94%. This...

Middle East tensions put Golar LNG (GLNG) in focus A missile attack on a major Qatari natural gas hub, a key supplier of global LNG, has pushed investors toward LNG exposed names such as Golar LNG (GLNG), amid concerns around potential supply disruptions. See our latest analysis for Golar LNG. The news-driven spike in LNG prices has been reflected in Golar LNG’s share price, with a 1-day share price return of 3.36%, a 7-day return of 17.41%, and a 90-day return of 41.36%. Total shareholder...

In March 2026, Locus Cell Co., Ltd. announced it had signed a Memorandum of Understanding with Charles River Laboratories to explore collaboration on CMC support, analytical testing, technical development, and related services for advanced therapy developers across Taiwan and the wider Asia-Pacific region. This agreement links Charles River’s global biologics testing expertise with Locus Cell’s cell and gene therapy manufacturing platforms, highlighting a potential build-out of integrated...

Relay Therapeutics recently reported updated Phase 1/2 ReDiscover trial data showing that zovegalisib (RLY-2608) plus fulvestrant at a 400mg twice-daily fed dose delivered efficacy and tolerability in PI3Ka-mutated, HR+/HER2- metastatic breast cancer consistent with its earlier 600mg fasted regimen, and confirmed this as the recommended Phase 3 dose. The data, presented at ESMO TAT 2026, underpin the ongoing global Phase 3 ReDiscover-2 trial and build on the regimen’s FDA Breakthrough...

Uber Technologies (NYSE:UBER) is rolling out a hybrid network that blends human drivers with autonomous robotaxis across select markets. Early operating data from these deployments indicates higher vehicle utilization and quicker pickup times when riders can choose between both options. The company is using these results to refine how it allocates trips between human drivers and autonomous partners on its platform. For investors watching NYSE:UBER, this hybrid approach ties directly to its...

Recent performance snapshot Benchmark Electronics (BHE) has attracted fresh attention after recent share moves, with the stock showing a 3.6% decline over the past day and about a 7.5% decline over the past month. See our latest analysis for Benchmark Electronics. While the recent 7.5% 30 day share price decline may feel uncomfortable, Benchmark Electronics still shows stronger momentum over longer periods, with a 90 day share price return of 20.9% and a 1 year total shareholder return of...

Some investors may be wondering whether Walmart's current share price still offers value after a strong run, or whether most of the potential upside is already reflected in the stock. Over the past year, the stock returned 37.2%, with year to date returns of 5.6% and shorter term moves of 3.2% over 30 days and 5.5% over 7 days. These moves may signal shifting views on risk and reward. Recent headlines have focused on Walmart's ongoing push into e commerce and membership offerings, as well as...

On 10 March 2026, the Human Animal Bond Research Institute announced a new partnership with Trupanion to align pet insurance with scientific research on the human–animal bond, including support for veterans and service dogs. This collaboration links Trupanion with evidence-based advocacy on how pets benefit physical and mental health, potentially strengthening its brand with veterinarians, pet owners, and mission-driven partners. We’ll now examine how Trupanion’s alignment with human–animal...

Earlier in March 2026, SM Energy Company issued US$1,000,000,000 of 6.625% Senior Notes due 2034 and launched an expanded cash tender offer of up to US$1,000,000,000 for its inherited 8.375% Senior Notes due 2028, with about 58.04% of the outstanding principal already tendered. This refinancing push highlights how SM Energy is actively reshaping its post‑Civitas debt stack, potentially lowering interest costs and extending its maturity profile. Next, we’ll examine how this large-scale debt...

In March 2026, United Natural Foods, Inc. reported second-quarter net income of US$20 million on sales of US$7.95 billion, raised full-year earnings guidance while trimming its sales outlook, completed a US$87.73 million share repurchase program, and advanced a major supply chain overhaul including a distribution center closure and job cuts. This combination of improved profitability, capital returns, and a shift toward automation and AI-enabled logistics marks a significant reshaping of how...

Recent share performance puts Global Payments in focus Global Payments (GPN) has drawn attention after a one-month return of about a 17% decline and a three-month return of roughly a 15% decline, prompting investors to reassess expectations around the payment technology group. See our latest analysis for Global Payments. The recent 1-month share price return of a 16.9% decline and 1-year total shareholder return of a 30.0% loss point to fading momentum, even with small gains over the past...